Analyses by HER2 status showed that the ORs of HER2− breast cancer declined with increasing lifetime MET-hours of physical activity (Ptrend = 0.04), whereas no trend was observed for HER2+ breast cancer (Ptrend = 0.93). The gene discussed is ERBB2; the disease is breast cancer.